t
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
Form 11-K
_________________________________________________________
|
|
|
|
|
|
|
x |
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2021
|
|
|
|
|
|
|
¨ |
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from
to
Commission file number: 001-35832
_________________________________________________________
|
|
|
|
|
|
|
A. |
Full title of plan and the address of the plan, if different from
that of the issuer named below: |
Science Applications International Corporation Retirement
Plan
|
|
|
|
|
|
|
B. |
Name of issuer of the securities held pursuant to the plan and the
address of its principal executive office: |
Science Applications International Corporation
12010 Sunset Hills Road
Reston, VA 20190
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page |
|
|
|
|
|
|
1 |
|
|
|
|
FINANCIAL STATEMENTS |
|
|
|
|
|
2 |
|
|
|
3 |
|
|
|
4 |
|
|
|
|
SUPPLEMENTAL SCHEDULE |
|
|
|
|
|
9 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
11 |
NOTE: All other schedules required by Section 29 CFR 2520.103-10 of
the Department of Labor’s Rules and Regulations for Reporting and
Disclosure under the Employee Retirement Income Security Act of
1974 have been omitted because they are not
applicable.
Report of Independent Registered Public Accounting
Firm
Benefit Plans Committee
Science Applications International Corporation Retirement
Plan
Opinion on the Financial Statements
We have audited the accompanying statements of net assets available
for benefits of the
Science Applications International Corporation Retirement
Plan
(the “Plan”) as of December 31, 2021 and 2020, and the related
statements of changes in net assets available for benefits for the
years then ended, and the related notes (collectively referred to
as the financial statements). In our opinion, the financial
statements present fairly, in all material respects, the net assets
available for benefits of the Plan as of December 31, 2021 and
2020, and the changes in net assets available for benefits for the
years then ended, in conformity with accounting principles
generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Plan’s
management. Our responsibility is to express an opinion on the
Plan’s financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting
Oversight Board (United States) (PCAOB) and are required to be
independent with respect to the Plan in accordance with the U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error
or fraud.
Our audits included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis
for our opinion.
Supplemental Information
The Schedule of Assets (Held at Year End) as of December 31, 2021
(collectively referred to as the supplemental information) has been
subjected to audit procedures performed in conjunction with the
audit of the Plan’s financial statements. The supplemental
information is the responsibility of the Plan’s management. Our
audit procedures included determining whether the supplemental
information reconciles to the financial statements or the
underlying accounting and other records, as applicable, and
performing procedures to test the completeness and accuracy of the
information presented in the supplemental information. In forming
our opinion on the supplemental information, we evaluated whether
the supplemental information, including its form and content, is
presented in conformity with the Department of Labor's Rules and
Regulations for Reporting and Disclosure under the Employee
Retirement Income Security Act of 1974. In our opinion, the
supplemental information is fairly stated, in all material
respects, in relation to the financial statements as a
whole.
/s/ Mayer Hoffman McCann P.C.
We have served as the Plan's auditor since 2013.
San Diego, California
June 22, 2022
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
December 31, |
|
|
|
|
2021 |
|
2020 |
|
|
|
|
|
(in thousands) |
|
ASSETS: |
|
|
|
|
Investments: |
|
|
|
|
|
Mutual funds |
$ |
1,452,848 |
|
|
$ |
1,433,296 |
|
|
Science Applications International Corporation common
stock |
96,734 |
|
|
109,413 |
|
|
|
Common collective trusts |
3,484,938 |
|
|
2,993,179 |
|
|
Self-directed brokerage fund |
90,682 |
|
|
75,026 |
|
|
|
|
Total investments |
5,125,202 |
|
|
4,610,914 |
|
|
Receivables: |
|
|
|
|
|
Notes receivable from participants |
29,078 |
|
|
29,852 |
|
|
Employer contributions |
21,267 |
|
|
19,868 |
|
|
|
Participant contributions |
1 |
|
|
— |
|
|
|
|
Total receivables |
50,346 |
|
|
49,720 |
|
|
Total assets |
5,175,548 |
|
|
4,660,634 |
|
|
LIABILITIES: |
|
|
|
|
Excess contributions due to participants |
1 |
|
|
— |
|
|
NET ASSETS AVAILABLE FOR BENEFITS |
$ |
5,175,547 |
|
|
$ |
4,660,634 |
|
See accompanying notes to financial statements.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR
BENEFITS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
|
December 31, |
|
December 31, |
|
|
|
|
2021 |
|
2020 |
|
|
|
|
|
(in thousands) |
|
INVESTMENT INCOME: |
|
|
|
|
|
Net appreciation in fair value of investments |
$ |
477,654 |
|
|
$ |
555,591 |
|
|
Interest and dividends |
93,221 |
|
|
61,956 |
|
|
|
|
Total investment income |
570,875 |
|
|
617,547 |
|
|
|
|
|
|
|
|
|
|
INTEREST INCOME ON NOTES RECEIVABLE FROM PARTICIPANTS |
1,495 |
|
|
1,733 |
|
|
|
|
|
|
|
|
|
|
CONTRIBUTIONS: |
|
|
|
|
Participants |
205,405 |
|
|
194,649 |
|
|
|
Employer |
78,755 |
|
|
74,329 |
|
|
Participant rollovers |
50,310 |
|
|
42,134 |
|
|
|
|
Total contributions |
334,470 |
|
|
311,112 |
|
|
|
|
|
|
|
|
|
|
DEDUCTIONS: |
|
|
|
|
Distributions paid to participants |
413,915 |
|
|
355,360 |
|
|
|
Administrative expenses |
2,305 |
|
|
1,931 |
|
|
|
|
Total deductions |
416,220 |
|
|
357,291 |
|
|
|
|
|
|
|
INCREASE IN NET ASSETS AVAILABLE FOR BENEFITS BEFORE
TRANSFERS |
490,620 |
|
|
573,101 |
|
|
|
|
|
|
|
|
|
|
NET TRANSFERS FROM OTHER PLANS |
24,293 |
|
|
1,071,593 |
|
|
|
|
|
|
|
|
|
|
INCREASE IN NET ASSETS AVAILABLE FOR BENEFITS |
514,913 |
|
|
1,644,694 |
|
|
|
|
|
|
|
|
|
|
NET ASSETS AVAILABLE FOR BENEFITS: |
|
|
|
|
|
Beginning of year |
4,660,634 |
|
|
3,015,940 |
|
|
|
End of year |
$ |
5,175,547 |
|
|
$ |
4,660,634 |
|
See accompanying notes to financial statements.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
NOTES TO FINANCIAL STATEMENTS
1. DESCRIPTION OF THE PLAN
The following brief description of the Science Applications
International Corporation Retirement Plan (the “Plan”) is for
general information purposes only. Participants should refer to the
Plan document and the Summary Plan Description for complete
information regarding the Plan. Within these financial statements,
Science Applications International Corporation (the “Company”)
refers to the sponsoring employer.
General—The
Plan is a defined contribution plan sponsored by the Company and is
subject to the provisions of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”). The Plan is a 401(k)
plan with profit-sharing and employee stock ownership plan (“ESOP”)
features. Both employee and Company contributions to the Plan are
held in a qualified retirement trust fund. The Science Applications
International Corporation Benefit Plans Committee is the Plan’s
named fiduciary for purposes of Section 402(a) of
ERISA.
Investment Funds—As
of December 31, 2021, the Plan held investments in 7 mutual funds,
20 common collective trust funds, a self-directed brokerage fund,
and 2 Company stock funds: the SAIC Common Stock Fund and the SAIC
Closed Stock Fund (collectively, the “Stock Funds”). All amounts in
the Stock Funds are invested in Science Applications International
Corporation common stock, except for estimated cash reserves, which
are invested in the Vanguard Federal Money Market Fund and are
primarily used to provide future benefit distributions and
facilitate investment exchanges.
Eligibility—Employees
of the Company are eligible to participate in the Plan. Employees
must be in an eligible fringe benefit package to be eligible to
receive Company matching 401(k) contributions. Generally, employees
may make elective contributions and receive Company matching 401(k)
contributions upon commencing employment.
Participant Contributions—The
Plan permits participants to contribute up to 75% of their eligible
compensation to the Plan, subject to statutory limitations.
Participants may also contribute amounts representing rollovers
from other qualified plans. Participant contributions are invested
according to participant direction into any of the available
investment funds of the Plan. Participant contributions and
rollovers to the SAIC Common Stock Fund are limited to a maximum of
50% of the employee deferral or rollover, as
applicable.
Employer Contributions—The
Company may make matching 401(k) contributions. Eligible
participants may receive Company matching 401(k) contributions
based on a percentage (up to a maximum match percentage of 4%),
depending on the fringe benefit package, which are invested per
participant direction. Company contributions to the Plan for the
Plan years ended December 31, 2021 and 2020 were made in cash. The
Company, at its discretion, may also make additional contributions
to the Plan for the benefit of non-highly compensated participants
in order to comply with Section 401(k) (3) of the Internal Revenue
Code ("IRC"); however, the Company made no such additional
contributions for the Plan years ended December 31, 2021 and
2020.
Participant Accounts—In
accordance with Plan provisions, individual accounts are maintained
for each Plan participant. Each participant’s account is credited
with the participant’s contributions, and if eligible, allocations
of Company contributions. Allocations are based on participant
eligible compensation, as defined in the Plan document. Participant
accounts also reflect changes from investment income and losses and
from distributions. The benefit to which a participant is entitled
is the vested balance of his or her account.
Plan Amendments and Termination—Effective
January 1, 2020, the Plan was amended to merge the Engility Master
Savings Plan ("MSP") into the Plan and to adopt certain other
provisions regarding vesting of MSP balances and timing of Company
contributions. This was in connection with the Company's
acquisition of Engility Corporation during the year ended December
31, 2019.
Effective February 20, 2020, the Plan was amended to authorize
special disaster distributions to eligible participants who are
residents of Puerto Rico.
Effective December 1, 2021, the Plan was amended to merge the
Halfaker & Associates LLC 401(k) Plan ("Halfaker Plan") into
the Plan and to adopt certain other provisions regarding vesting of
Halfaker Plan balances. This was in connection with the Company's
acquisition of Halfaker & Associates LLC during the year ended
December 31, 2021. Final regulations on hardship distributions
promulgated under Section 401(k) of the IRC were also
adopted.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
NOTES TO FINANCIAL STATEMENTS
Although it has not expressed any intent to do so, the Company has
the right under the Plan to discontinue its contributions and to
terminate the Plan at any time subject to the provisions of
ERISA.
Vesting and Forfeitures—Participants’
elective deferrals, rollover contributions and Company
contributions together with associated earnings vest immediately.
Company contributions included in participants' balances in the MSP
and Halfaker Plan that were merged into the Plan will continue to
vest according the vesting schedules in those plans prior to the
mergers, vesting ratably over periods of 3 and 5 years,
respectively. Forfeitures are used to offset Company contributions
or certain eligible Plan expenses. Forfeitures amounted to
approximately $682,000 and $791,000 for the years ended December
31, 2021 and 2020, respectively.
Notes Receivable from Participants—Participants
may borrow up to 50% of their vested account balance, up to a
maximum of $50,000. Loan repayment periods may not exceed 60 months
except for loans used to acquire a principal residence, in which
case the repayment period may not exceed 30 years. If a participant
defaults on a loan, it becomes a deemed distribution from the Plan
to the participant. The loans bear interest at a rate commensurate
with local prevailing rates as determined monthly by the Plan
administrator. Principal and interest are collected ratably through
payroll deductions.
Distributions to Participants—For
vested account balances less than $1,000, participants receive
their vested account balance in a single lump sum following
termination of employment with the Company. For vested account
balances between $1,000 and $5,000, a participant’s vested account
balance is automatically rolled over into an Individual Retirement
Account. For vested account balances that exceed $5,000, balances
are not distributed unless the participant elects to take a
distribution following the participant’s termination of employment
with the Company. Regardless of the existing account balance,
distributions are made when participants die or become permanently
disabled while employed by the Company. After attaining the age of
59-1/2, a participant may make withdrawals even if still employed
by the Company. Participants may make withdrawals from the Plan
prior to attaining the age of 59-1/2 from their rollover account or
if the participant incurs a financial hardship, as specified by the
Plan document. Former employees, regardless of their age, may elect
to receive up to two distributions in any given Plan year, of all
or a portion of their account balance.
Tax Status—The
Internal Revenue Service (“IRS”) has determined and informed the
Company by a letter dated February 28, 2014, that the Plan was
designed in accordance with the applicable requirements of the IRC.
Although the Plan has been amended since receiving the
determination letter, the Company and the Plan’s tax counsel
believe that the Plan is designed, and is currently being operated,
in compliance with the applicable requirements of the IRC and,
therefore, believe that the Plan is qualified, and the related
trust is tax-exempt. Accordingly, no provision for income taxes has
been included in the Plan’s financial statements. Management
recognizes tax liabilities for uncertainty in income taxes when it
is more likely than not that a tax position would not be sustained
upon examination by and settlement with the IRS. The Plan is
subject to routine audits by taxing jurisdictions, and the
Company's tax returns for its fiscal years 2016 through 2019
(generally corresponding to Plan years 2015 through 2018) are
currently under audit by the IRS. Management believes it is no
longer subject to income tax examinations for Plan years prior to
2015.
Related-Party Transactions—Certain
Plan investments are managed by The Vanguard Group, the Plan’s
record-keeper; therefore, transactions with these investments
qualify as party-in-interest transactions. Fees paid to the
record-keeper were approximately $2,150,000 and $1,760,000 for the
years ended December 31, 2021 and 2020, respectively. There were no
amounts payable to the Plan’s record-keeper as of December 31, 2021
and 2020. Members of the Science Applications International
Corporation Benefit Plans Committee also participate in the Plan
and qualify as parties-in-interest.
Science Applications International Corporation is the sponsoring
employer as of December 31, 2021 and 2020. At December 31, 2021 and
2020, the following Science Applications International Corporation
shares were held by the Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
2020 |
|
Number of Shares |
|
Cost Basis |
|
Number of Shares |
|
Cost Basis |
|
(in thousands) |
|
Science Applications International Corporation common
stock |
1,161 |
|
$61,797 |
|
|
1,156 |
|
$56,076 |
|
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
NOTES TO FINANCIAL STATEMENTS
Transfers from Other Plans—In
connection with the mergers of the Halfaker Plan and the MSP into
the Plan, the undistributed participant account balances were
transferred into the Plan. Net transfers from other plans reported
in the statements of changes in net assets are summarized as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
|
December 31, 2021 |
|
December 31, 2020 |
|
(in thousands) |
|
Halfaker Plan |
$ |
24,293 |
|
|
$ |
— |
|
|
MSP |
— |
|
|
1,071,593 |
|
|
Net transfers from other plans |
$ |
24,293 |
|
|
$ |
1,071,593 |
|
COVID-19 Impact—In
March 2020, the World Health Organization (“WHO”) categorized
Coronavirus Disease 2019 (“COVID-19”) as a pandemic. Following the
WHO’s declaration, the United States government passed the
“Coronavirus Aid, Relief, and Economic Security (CARES) Act” on
March 27, 2020. The CARES Act provides for various forms of relief
for qualifying Plan participants including penalty-free
distributions, increased limits for plan loans, suspension of loan
payments for up to one year, and delaying required minimum
distributions. The Plan has implemented these changes.
2. SIGNIFICANT ACCOUNTING
POLICIES
Basis of Accounting—The
Plan’s financial statements are prepared in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”).
Investment Valuation and Income Recognition—Investments
held by the Plan are carried at fair value. Valuation and income
recognition policies are as follows:
Investment in Mutual Funds—The
Plan’s investments in mutual funds are stated at fair value based
on quoted market prices.
Investment in Common Collective Trusts—The
Plan's investments in common collective trusts are carried at net
asset value (“NAV”) per unit, which is determined by the trustee
using the fair value of the underlying investments.
Investment in Common Stock—Investments
in shares of Science Applications International Corporation common
stock, which are publicly traded on the New York Stock Exchange,
are recorded at their last quoted market price on the last business
day of the respective plan year.
Self-Directed Brokerage Fund—The
Plan’s investments in the self-directed brokerage fund are stated
at fair value based on quoted market prices.
Investment Gains and Losses—Realized
gains and losses on sales of investments are calculated as the
difference between the fair value of the investments upon sale and
the fair value of the investments at purchase. Unrealized
appreciation or depreciation is calculated as the difference
between the fair value of the investments at the end of the year
and the fair value of the investments at the beginning of the year
or on the date of purchase if purchased during the year. Interest
income is recorded as earned, and dividends are recorded on the
ex-dividend date.
Investment Risks and Uncertainties—The
Plan invests in various investment securities which, in general,
are exposed to various risks, such as interest rate risk, credit
risk, and overall market volatility. Due to the level of risk
associated with investment securities, it is reasonably possible
that changes in the values of certain investment securities will
occur in the near term and such changes could materially affect the
amounts reported in the statement of net assets available for
benefits and statement of changes in net assets available for
benefits.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
NOTES TO FINANCIAL STATEMENTS
Notes Receivable from Participants—Notes
receivable from participants are carried at the aggregate unpaid
principal balance, plus accrued, unpaid interest of loans
outstanding.
Benefits Payable—Benefit
payments to participants are recorded upon distribution. There were
no benefits payable to participants who had elected to withdraw
from the Plan but had not yet been paid as of December 31, 2021 and
2020.
Use of Estimates—The
preparation of financial statements in conformity with GAAP
requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosures of
contingent assets and liabilities at the date of the financial
statements, and the reported amounts of additions and deductions
during the reporting periods. Actual results may differ from those
estimates.
Administrative Expenses—Administrative
expenses of the Plan are paid by the Plan sponsor or Plan
participants as provided in the Plan document.
3. FAIR VALUE MEASUREMENTS
Accounting guidance has been issued that establishes a framework
for measuring fair value. That framework provides a fair value
hierarchy that prioritizes the inputs to valuation techniques used
to measure fair value. The three levels of the fair value hierarchy
are described below:
Level 1 Unadjusted quoted prices for
identical assets or liabilities in active markets that the Plan has
the ability to access.
Level 2 Inputs to the valuation methodology
include: quoted prices for similar assets or liabilities in active
markets; quoted prices for identical or similar assets or
liabilities in inactive markets; inputs other than quoted prices
that are observable for the asset or liability; and inputs that are
derived principally from or corroborated by observable market data
by correlation or other means. If the asset or liability has a
specified (contractual) term, the Level 2 inputs must be observable
for substantially the full term of the asset or
liability.
Level 3 Inputs to the valuation methodology
are unobservable and significant to the fair value
measurement.
The following table sets forth the Plan’s investments at fair value
and by level, as applicable, as of December 31, 2021 and
2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
|
(in thousands) |
|
Mutual funds |
|
$ |
1,452,848 |
|
|
$ |
1,433,296 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,452,848 |
|
|
$ |
1,433,296 |
|
|
Common stock |
|
96,734 |
|
|
109,413 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
96,734 |
|
|
109,413 |
|
|
Self-directed brokerage fund |
|
90,682 |
|
|
75,026 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
90,682 |
|
|
75,026 |
|
|
Subtotal |
|
$ |
1,640,264 |
|
|
$ |
1,617,735 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,640,264 |
|
|
$ |
1,617,735 |
|
|
Common collective trusts—measured at NAV |
|
|
|
|
|
|
|
|
|
3,484,938 |
|
|
2,993,179 |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
5,125,202 |
|
|
$ |
4,610,914 |
|
Common collective trusts are measured at fair value using NAV as a
practical expedient and have not been categorized in the fair value
hierarchy. The fair value amounts presented in the table are
intended to permit reconciliation of the fair value hierarchy to
the amounts presented in the Statements of Net Assets Available for
Benefits. The Plan has no unfunded commitments to the common
collective trusts, and there are no redemption
restrictions.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
NOTES TO FINANCIAL STATEMENTS
4. SUBSEQUENT EVENTS
In preparing the accompanying financial statements, management of
the Plan has evaluated all subsequent events and transactions for
potential recognition or disclosure through June 22, 2022, the
date the financial statements were available for
issuance.
******
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT
PLAN
SUPPLEMENTAL SCHEDULE
FORM 5500, SCHEDULE H, PART IV, LINE 4i—SCHEDULE OF ASSETS (HELD AT
END OF YEAR)
AS OF DECEMBER 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EIN: 30-6419427 |
|
Plan #001 |
|
|
Identity of Issue, Borrower, Lessor, or Similar Party |
|
Description of Investment Including Maturity Date, Rate of Interest
and Collateral |
|
Cost |
|
Current Value |
|
|
|
|
|
|
(in thousands) |
|
* |
Science Applications International Corporation common
stock |
|
Company Stock |
|
** |
|
$ |
96,734 |
|
|
* |
Dodge & Cox Stock Fund |
|
Mutual Fund |
|
** |
|
243,750 |
|
|
T. Rowe Price Institutional Mid Cap Equity Growth Fund |
|
Mutual Fund |
|
** |
|
187,644 |
|
* |
Vanguard FTSE All-World ex-US Index: Institutional
Shares |
|
Mutual Fund |
|
** |
|
178,597 |
|
* |
Vanguard Federal Money Market Fund |
|
Mutual Fund |
|
** |
|
259,679 |
|
* |
Vanguard International Growth Fund Admiral Shares |
|
Mutual Fund |
|
** |
|
177,361 |
|
* |
Vanguard PRIMECAP Fund Admiral Shares |
|
Mutual Fund |
|
** |
|
362,546 |
|
* |
Vanguard Short-Term Bond Index Fund Institutional |
|
Mutual Fund |
|
** |
|
43,271 |
|
|
Columbia Trust Emerging Markets Equity Fund; Founders
Cl |
|
Common Collective Trust |
|
** |
|
50,835 |
|
Loomis Sayles Core Plus Fixed Income Trust Class C |
|
Common Collective Trust |
|
** |
|
93,225 |
|
|
T. Rowe Price U.S. Mid Cap-Value Equity Trust; D Class |
|
Common Collective Trust |
|
** |
|
55,023 |
|
* |
Vanguard Institutional 500 Index Trust |
|
Common Collective Trust |
|
** |
|
714,849 |
|
* |
Vanguard Institutional Extended Market Index Trust |
|
Common Collective Trust |
|
** |
|
265,349 |
|
* |
Vanguard Institutional Total Bond Market Index Trust |
|
Common Collective Trust |
|
** |
|
234,047 |
|
* |
Vanguard Target Retirement 2015 Trust Plus |
|
Common Collective Trust |
|
** |
|
61,192 |
|
* |
Vanguard Target Retirement 2020 Trust Plus |
|
Common Collective Trust |
|
** |
|
217,153 |
|
* |
Vanguard Target Retirement 2025 Trust Plus |
|
Common Collective Trust |
|
** |
|
364,583 |
|
* |
Vanguard Target Retirement 2030 Trust Plus |
|
Common Collective Trust |
|
** |
|
370,986 |
|
* |
Vanguard Target Retirement 2035 Trust Plus |
|
Common Collective Trust |
|
** |
|
245,399 |
|
* |
Vanguard Target Retirement 2040 Trust Plus |
|
Common Collective Trust |
|
** |
|
199,211 |
|
* |
Vanguard Target Retirement 2045 Trust Plus |
|
Common Collective Trust |
|
** |
|
162,699 |
|
* |
Vanguard Target Retirement 2050 Trust Plus |
|
Common Collective Trust |
|
** |
|
119,056 |
|
* |
Vanguard Target Retirement 2055 Trust Plus |
|
Common Collective Trust |
|
** |
|
56,682 |
|
* |
Vanguard Target Retirement 2060 Trust Plus |
|
Common Collective Trust |
|
** |
|
27,060 |
|
* |
Vanguard Target Retirement 2065 Trust Plus |
|
Common Collective Trust |
|
** |
|
7,930 |
|
* |
Vanguard Target Retirement Income Trust Plus |
|
Common Collective Trust |
|
** |
|
79,507 |
|
|
Wellington Trust Small Cap 2000 |
|
Common Collective Trust |
|
** |
|
135,858 |
|
Wellington Trust TIPS |
|
Common Collective Trust |
|
** |
|
24,294 |
|
|
Self-Directed Brokerage Fund |
|
Various |
|
** |
|
90,682 |
|
* |
Notes Receivable from Participants |
|
Loans/Interest rates from 4.25% to 9.25%; maturities from January
2022 to November 2051 |
|
** |
|
29,078 |
|
|
|
|
|
|
|
|
|
* |
Indicates party-in-interest to the Plan |
|
|
|
|
|
|
|
** |
Not applicable - Historical cost information is not required to be
presented, as all investments are participant-directed. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Science Applications International Corporation Benefit
Plans Committee has duly caused this annual report to be signed on
its behalf by the undersigned hereunto duly
authorized.
By: Science Applications International Corporation Benefit Plans
Committee
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: June 22, 2022 |
|
|
/s/ Paul C. Lehrer |
|
|
|
Paul C. Lehrer |
|
|
|
Authorized Official |
|
|
|
Science Applications International Corporation |
Exhibit Index
|
|
|
|
|
|
|
|
|
|
Exhibit No. |
|
Description of Exhibit |
|
|
|
|
|
|
|
|
Science Applications (NYSE:SAIC)
Historical Stock Chart
From Dec 2022 to Jan 2023
Science Applications (NYSE:SAIC)
Historical Stock Chart
From Jan 2022 to Jan 2023
